The experience of dual biologic therapy in patients with eosinophilic asthma and autoimmune diseases
A. Matthaiou (Heraklion, Greece), N. Bizymi (Heraklion, Greece), L. Ettronier (Montpellier, France), E. Bibaki (Heraklion, Greece), J. Morel (Montpellier, France), N. Tzanakis (Heraklion, Greece), A. Bourdin (Montpellier, France), K. Antoniou (Heraklion, Greece)
Source: International Congress 2022 – Asthma biologics in real life studies
Session: Asthma biologics in real life studies
Session type: Thematic Poster
Number: 2393
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Matthaiou (Heraklion, Greece), N. Bizymi (Heraklion, Greece), L. Ettronier (Montpellier, France), E. Bibaki (Heraklion, Greece), J. Morel (Montpellier, France), N. Tzanakis (Heraklion, Greece), A. Bourdin (Montpellier, France), K. Antoniou (Heraklion, Greece). The experience of dual biologic therapy in patients with eosinophilic asthma and autoimmune diseases. 2393
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|